Award Symposium: The LCGC Lifetime Achievement and Emerging Leader Awards
This afternoon, the winners of the LCGC Awards will be honored in an oral symposium at Pittcon. Milton L. Lee of Brigham Young University will receive the 2016 LCGC Lifetime Achievement Award at 1:30, and Debby Mangelings of the Free University of Brussels (Vrie Universiteit Brussel), will receive the 2016 LCGC Emerging Leader Award at 3:45 pm, just after the break. The symposium will be held in room B314.
This afternoon, the winners of the LCGC Awards will be honored in an oral symposium at Pittcon. Milton L. Lee of Brigham Young University will receive the 2016 LCGC Lifetime Achievement Award at 1:30, and Debby Mangelings of the Free University of Brussels (Vrie Universiteit Brussel), will receive the 2016 LCGC Emerging Leader Award at 3:45 pm, just after the break. The symposium will be held in room B314. Following the presentation of the Lifetime Achievement Award, Lee will give a talk on columns in small-scale chromatography. Pat Sandra of the Research Institute for Chromatography will then discuss recent chromatographic and mass spectrometric developments applied to the characterization of recombinant proteins, monoclonal antibodies, and antibody-drug conjugates. Rounding out the first part of the program, Milos Novotny of Indiana University will give a presentation entitled, “Analytical Glycoscience: Quo Vadis?” After receiving the Emerging Leader Award, Mangelings will discuss generic chiral separation strategies for pharmaceutical compounds using chromatographic and electrophoretic techniques. Bezhan Chankvetadze of Tbilisi State University will then discuss recent trends in HPLC separation of enantiomers. Read about Lee and Mangelings in the article in our February issue.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
